Factors Influencing Atypical Clinical Presentations during the 2017 Madagascar Pneumonic Plague Outbreak: A Prospective Cohort Study

In late 2017, Madagascar experienced a large urban outbreak of pneumonic plague, the largest outbreak to date this century. During the outbreak, there were widespread reports of plague patients presenting with atypical symptoms, such as prolonged duration of illness and upper respiratory tract sympt...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of tropical medicine and hygiene Vol. 102; no. 6; pp. 1309 - 1315
Main Authors Salam, Alex P., Raberahona, Mihaja, Andriantsalama, Prisca, Read, Liam, Andrianarintsiferantsoa, Faraniaina, Razafinambinintsoa, Tiana, Rakotomalala, Rado, Hasiniatsy, Rodrigue N. E., Razafimandimby, Dominique, Castle, Lyndsey, Funk, Anna, Mangahasimbola, Reziky T., Renaud, Bertrand, Bertherat, Eric, Lovering, Andrew, Heraud, Jean-Michel, Andrianaivoarimanana, Voahangy, Frédérique, Randrianirina, Razanajatovo, Norosoa, Baril, Laurence, Fontanet, Arnaud, Rajerison, Minoarisoa, Horby, Peter, Randria, Mamy, Randremanana, Rindra
Format Journal Article
LanguageEnglish
Published United States Institute of Tropical Medicine 01.06.2020
American Society of Tropical Medicine and Hygiene
The American Society of Tropical Medicine and Hygiene
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In late 2017, Madagascar experienced a large urban outbreak of pneumonic plague, the largest outbreak to date this century. During the outbreak, there were widespread reports of plague patients presenting with atypical symptoms, such as prolonged duration of illness and upper respiratory tract symptoms. Reported mortality among plague cases was also substantially lower than that reported in the literature (25% versus 50% in treated patients). A prospective multicenter observational study was carried out to investigate potential reasons for these atypical presentations. Few subjects among our cohort had confirmed or probable plague, suggesting that, in part, there was overdiagnosis of plague cases by clinicians. However, 35% subjects reported using an antibiotic with anti-plague activity before hospital admission, whereas 55% had antibiotics with anti-plague activity detected in their serum at admission. Although there may have been overdiagnosis of plague by clinicians during the outbreak, the high frequency of community antibiotic may partly explain the relatively few culture-positive sputum samples during the outbreak. Community antibiotic use may have also altered the clinical presentation of plague patients. These issues make accurate detection of patients and the development of clinical case definitions and triage algorithms in urban pneumonic plague outbreaks difficult.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC7253123
Financial support: This study was funded by the United Kingdom Public Health Rapid Support Team.
Authors’ addresses: Alex P. Salam, Lyndsey Castle, and Peter Horby, University of Oxford, Oxford, United Kingdom, E-mails: alex.salam@ndm.ox.ac.uk, lyndsey.castle@ndm.ox.ac.uk, and peter.horby@ndm.ox.ac.uk. Mihaja Raberahona, Tiana Razafinambinintsoa, Rado Rakotomalala, and Mamy Randria, Centre Hospitalier Befelatanana, Antananarivo, Madagascar, E-mails: raberahona@gmail.com, jdnambinintsoa@gmail.com, rakotomalalaradodhunant@gmail.com, and rmamyjeandedieu@yahoo.fr. Prisca Andriantsalama, Reziky T. Mangahasimbola, Jean-Michel Heraud, Voahangy Andrianaivoarimanana, Randrianirina Frédérique, Norosoa Razanajatovo, Laurence Baril, Minoarisoa Rajerison, and Rindra Randremanana, Institut Pasteur de Madagascar, Antananarivo, Madagascar, E-mails: pandriatsalama@pasteur.mg, mreziky@pasteur.mg, jmheraud@pasteur.mg, kekely@pasteur.mg, frederique@pasteur.mg, norosoa@pasteur.mg, lbaril@pasteur.mg, mino@pasteur.mg, and rrandrem@pasteur.mg. Liam Read and Andrew Lovering, North Bristol NHS trust, Bristol, United Kingdom, E-mails: liam.read@nbt.nhs.uk and andrew.lovering@nbt.nhs.uk. Faraniaina Andrianarintsiferantsoa, Centre Hospitalier Anti-Pesteux d’Ambohimiandra, Antananarivo, Madagascar, E-mail: drfaraniaina@gmail.com. Rodrigue N. E. Hasiniatsy and Dominique Razafimandimby, Centre Hospitalier de Soavinandriana, Antananarivo, Madagascar, E-mails: hasiniatsy.rodrigue@yahoo.fr and d.razafimandimby@yahoo.fr. Anna Funk and Arnaud Fontanet, Institut Pasteur Paris, Paris, France, E-mails: anna-louise.funk@pasteur.fr and arnaud.fontanet@pasteur.fr. Bertrand Renaud, Université Paris Descartes, Paris, France, E-mail: bertrand.renaud@parisdescartes.fr. Eric Bertherat, World Health Organization, Geneva, Switzerland, E-mail: bertherate@who.int.
These authors contributed equally to this work.
ISSN:0002-9637
1476-1645
1476-1645
DOI:10.4269/ajtmh.19-0576